Providence Proton is partnering with St. Vincent's Birmingham (a Member of the St. Vincent's Health System and Ascension) and its Bruno Cancer Center, Southeastern Oncology Associates and Susan Salter MD to bring advanced proton therapy cancer treatment to the Birmingham regions of Alabama.

Providence Proton has also chosen as one of its partners IBA (Ion Beam Applications S.A.), a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. IBA is the first proton therapy equipment company to have achieved proton therapy regulatory clearance by the FDA in the United States, CE marking in Europe, GOST clearance in Russia, SHONIN in Japan, as well as KFDA clearance in Korea.

Providence Proton and St. Vincent's will deploy the Proteus®ONE which is IBA's compact single room proton therapy solution.

The Providence and St. Vincent's Proton Center will be located on the campus of St. Vincent's Birmingham. The Proton Center development costs are expected to be in excess of $50 million, and a typical center takes two years to complete.  Ground-breaking is expected over the next 6 months and the center will open in 2019.